Overview
John Moody is a Radiation Oncologist in Greensboro, North Carolina. Dr. Moody is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Moody is currently accepting new patients.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
501 N Elam Ave, Greensboro, NC 27403
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Health Integrated Practice Inc
Christopher Kelsey is a Radiation Oncologist in Durham, North Carolina. Dr. Kelsey is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). Dr. Kelsey is currently accepting new patients.
Greensboro Radiation Oncologists PA
James Kinard is a Radiation Oncologist in Greensboro, North Carolina. Dr. Kinard is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Kinard is currently accepting new patients.
University Of North Carolina At Chapel Hill
Ashley Weiner is a Radiation Oncologist in Chapel Hill, North Carolina. Dr. Weiner is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Vulvar Cancer, Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Weiner is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Moody isDistinguished. Learn about Breast Cancer.
- Pleuropulmonary BlastomaDr. Moody isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Moody isAdvanced. Learn about Anal Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Familial Pancreatic CancerDr. Moody isAdvanced. Learn about Familial Pancreatic Cancer.
- Gallbladder AdenocarcinomaDr. Moody isAdvanced. Learn about Gallbladder Adenocarcinoma.
- HER-2 Positive Breast CancerDr. Moody isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Moody isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AngiosarcomaDr. Moody isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Moody isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Brain TumorDr. Moody isExperienced. Learn about Brain Tumor.
- Cervical CancerDr. Moody isExperienced. Learn about Cervical Cancer.